argenx SE
Market Cap
$48.38B
P/E Ratio
39.86
EPS
$19.61
Dividend Yield
0.00%
52-Week Range
$510.06 — $934.62
Volume
373.11K
Avg Volume
342.78K
Beta
-0.09
Get alerted when ARGX hits your target price.
Free — enter your email to get started
P/E (TTM)
39.86
Forward P/E
28.64
PEG Ratio
0.74
P/S (TTM)
14.53
P/B (TTM)
6.65
P/FCF
110.16
EV/EBITDA
123.62x
EV/Sales
—
ROE (TTM)
0.17%
ROA (TTM)
0.13%
ROIC
0.03%
Gross Margin
0.89%
Operating Margin
0.26%
Net Margin
0.26%
Debt/Equity
0.01
Current Ratio
5.23
EPS Growth (YoY)
+2.71%
Revenue Growth (YoY)
+0.59%
EPS Growth (3Y)
+1.22%
EPS Growth (5Y)
+0.44%
Sales Growth (3Y)
+0.87%
Sales Growth (5Y)
+2.64%
EPS Est (This Year)
$27.29
EPS Est (Next Year)
$35.79
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$72.30
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $1026.71(31.3% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
61.88M
Float
61.65M
Free Float %
99.62%
Sector
Healthcare
Industry
Biotechnology
Country
NL
Exchange
NASDAQ
IPO Date
2017-05-18
Employees
1599
CEO
Timothy Van Hauwermeiren
Index Membership
—
Website
https://www.argenx.com
argenx SE (ARGX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $48.38B, a P/E ratio of 39.86, ARGX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ARGX against other stocks using dozens of fundamental and technical filters.
argenx SE (ARGX) has a trailing twelve-month (TTM) P/E ratio of 39.86. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, argenx SE (ARGX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
argenx SE (ARGX) has a market capitalization of $48.38 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on argenx SE (ARGX) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $1026.71 implies 31.3% upside from the current price.